Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial - The Lancet Oncology
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
Predictors of Long-Term Outcome after Percutaneous Balloon Mitral Valvuloplasty | NEJM
Disease Free Survival - an overview | ScienceDirect Topics
Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia | Annals of Hematology
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia | Nature Communications
Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group | Haematologica
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
Validity of event-free survival as a surrogate endpoint in haematological malignancy: Review of the literature and health technology assessments - ScienceDirect
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions | British Journal of Cancer
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Survival Analysis in Python (KM Estimate, Cox-PH and AFT Model) | by Rahul Raoniar | The Researchers' Guide | Medium
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Validity of event-free survival as a surrogate endpoint in haematological malignancy: Review of the literature and health technology assessments - ScienceDirect
Are there differences between progression-free survival, relapse-free survival, and recurrence-free survival? | ResearchGate
Predictors of outcomes in hematopoietic cell transplantation for Fanconi anemia | Bone Marrow Transplantation
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma | NEJM
Disease-free Survival and Invasive-Disease-free Survival in the... | Download Scientific Diagram
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Event-free survival and overall survival (A) Event-free survival for... | Download Scientific Diagram
Progression-free survival (PFS) (A) and overall survival (OS) (B) based... | Download Scientific Diagram
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Median overall survival (mOS) and median progression-free survival... | Download Scientific Diagram
